Prevalence and functional consequence of TP53 mutations in pediatric adrenocortical carcinoma: a children's oncology group study.
about
Mouse Models Recapitulating Human Adrenocortical Tumors: What Is Lacking?The challenge of developmental therapeutics for adrenocortical carcinomaGenomic landscape of paediatric adrenocortical tumours.Pediatric Cancer Genetics Research and an Evolving Preventive Ethics Approach for Return of Results after Death of the Subject.Mouse models of adrenocortical tumors.5th International ACC Symposium: Hereditary Predisposition to Childhood ACC and the Associated Molecular Phenotype: 5th International ACC Symposium Session: Not Just for Kids!5th International ACC Symposium: An Outlook to Current and Future Research on the Biology of Adrenocortical Carcinoma: Diagnostic and Therapeutic Applications.Contribution of the TP53 R337H mutation to the cancer burden in southern Brazil: Insights from the study of 55 families of children with adrenocortical tumors.Super-Transactivation TP53 Variant in the Germline of a Family with Li-Fraumeni Syndrome.Li-Fraumeni syndrome: a paradigm for the understanding of hereditary cancer predisposition.Inherited TP53 Mutations and the Li-Fraumeni Syndrome.Ethical considerations surrounding germline next-generation sequencing of children with cancer.Challenges in surgical pathology of adrenocortical tumours.Identification of Clinical and Biologic Correlates Associated With Outcome in Children With Adrenocortical Tumors Without Germline TP53 Mutations: A St Jude Adrenocortical Tumor Registry and Children's Oncology Group Study.Is there a role for epithelial-mesenchymal transition in adrenocortical tumors?A Novel TP53 Mutation Associated with TWIST1 and SIP1 Expression in an Aggressive Adrenocortical Carcinoma.Adrenocortical carcinoma characterized by gynecomastia: A case report.Advances in the Treatment of Pediatric Bone Sarcomas.Childhood cancer predisposition syndromes-A concise review and recommendations by the Cancer Predisposition Working Group of the Society for Pediatric Oncology and Hematology.Pediatric High Grade Gliomas in the Context of Cancer Predisposition Syndromes.Therapeutic Targets for Adrenocortical Carcinoma in the Genomics EraIncidence of adrenal gland tumor as a second primary malignancy: SEER-based studySurvival in males with glioma and gastric adenocarcinoma correlates with mutant p53 residual transcriptional activityClinical relevance of screening checklists for detecting cancer predisposition syndromes in Asian childhood tumours
P2860
Q26740687-F1FA558C-F9DB-450F-9067-B3A759124DBCQ28072970-2EF8BA1E-4770-4B3B-ADA5-39A5DDE16D80Q35156692-2AD44FD8-82F8-415B-8313-08038F82D1B8Q36197118-A3706499-7515-4E2D-990A-683AD6B7DE49Q36482758-A7450974-C6A7-43A6-B158-6D4934C18695Q38667422-52848251-2825-453C-8454-FE1B28BEF54AQ38668953-FEC46ADC-827C-4CB9-985C-DEE40D6435F1Q38848062-A579758B-776B-4EC5-B2AC-3F92946E56F9Q38853700-E2C2C553-127E-419F-9537-C5805DA5AFCEQ39041480-12310BCD-7D5E-4F18-B545-5B2F5106072FQ39167055-340862AC-9536-4664-8D63-4FB4194F0487Q39235246-9118E66B-9B08-4B0D-B537-9B8BBB58EEEAQ47576824-6A245B1D-8020-4E55-AE15-A94A54C03F04Q47616676-FF215CDE-F9E9-49F3-A194-1F9A095FD22BQ48100155-453B7AA9-86D7-4D5A-A95B-1F824F5C765DQ48260919-3E66E2A7-6F9F-4F38-A0D6-F4FB60FF51C2Q49260033-972C0BE7-8D83-4A98-943D-29B46B20C68BQ50969326-4CD369E6-6920-4481-8219-C1425F57DF9FQ52793910-6D214A7F-4D7A-4803-81FE-94635DDE5AF8Q55277238-670A8B65-7315-485E-B917-32086EC19F3DQ58550571-50CF715D-624D-4F6E-8212-5DDDF62EEAEAQ58732194-C6E0C8C1-8421-45FE-B970-1762C0D8356CQ58792318-08982BB6-39EB-4286-9947-6B2A0DF3138BQ59136672-BECD4221-4CD7-43C4-92DC-CE452EF9237E
P2860
Prevalence and functional consequence of TP53 mutations in pediatric adrenocortical carcinoma: a children's oncology group study.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Prevalence and functional cons ...... ildren's oncology group study.
@ast
Prevalence and functional cons ...... ildren's oncology group study.
@en
type
label
Prevalence and functional cons ...... ildren's oncology group study.
@ast
Prevalence and functional cons ...... ildren's oncology group study.
@en
prefLabel
Prevalence and functional cons ...... ildren's oncology group study.
@ast
Prevalence and functional cons ...... ildren's oncology group study.
@en
P2093
P2860
P356
P1476
Prevalence and functional cons ...... ildren's oncology group study.
@en
P2093
Ana Novokmet
Carlos Rodriguez-Galindo
Claudia Eichler-Jonsson
Gerard P Zambetti
Jonathan D Wasserman
Raul C Ribeiro
P2860
P304
P356
10.1200/JCO.2013.52.6863
P407
P50
P577
2015-01-12T00:00:00Z